R&D Expenses
$121.73M
TTM · Period ending: · USD
PCRX R&D Expenses
Latest reported$121.73Mperiod ending
Latest reported$121.73Mperiod ending
PCRX R&D Expenses ($33.21M → $121.73M)
Annual R&D Expenses
High-resolution chart · PNG
PCRX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 117,312,000 | |
| 81,577,000 | |
| 76,257,000 | |
| 84,797,000 | |
| 55,545,000 | |
| 59,421,000 | |
| 72,119,000 | |
| 55,688,000 | |
| 57,290,000 | |
| 45,678,000 | |
| 28,662,000 | |
| 18,731,000 | |
| 21,560,000 | |
| 9,937,000 | |
| 14,873,000 | |
| 18,628,000 | |
| 26,233,000 | |
| 33,214,000 |